Assuntos
Hipertireoidismo/etiologia , Diagnóstico Diferencial , Humanos , Hipertireoidismo/diagnóstico , Hipertireoidismo/fisiopatologia , Hipertireoidismo/terapia , Neoplasias Hipofisárias/complicações , Neoplasias Hipofisárias/diagnóstico , Neoplasias Hipofisárias/metabolismo , Neoplasias Hipofisárias/terapia , Prognóstico , Síndrome da Resistência aos Hormônios Tireóideos/complicações , Síndrome da Resistência aos Hormônios Tireóideos/diagnóstico , Síndrome da Resistência aos Hormônios Tireóideos/terapia , Tireotropina/metabolismoRESUMO
We investigated the relationships between blood rheology assessed by microchannel method and the various hemorheologic factors in healthy subjects. One hundred seventy-six healthy volunteers (90 men and 86 women, mean age; 32.9+/-11.3 years) were participated in this study. Body weight, body mass index, red blood cell count, hematocrit, hemoglobin, white blood cell count, and platelet count, plasma fibrinogen, and fasting serum lipid and lipoprotein concentrations were measured. In order to assess blood rheology, blood passage time was determined by a microchannel method (Micro Channel Array Flow Analyzer). Age, body mass index, red blood cell count, hematocrit, hemoglobin, white blood cell count, total cholesterol, low-density lipoprotein cholesterol, and triglyceride were positively correlated with blood passage time in all subjects, respectively (p<0.01) and high-density lipoprotein cholesterol was inversely correlated with blood passage time (p<0.01). However, platelet count, and fibrinogen were not correlated with blood passage time. The present study showed that increased age, body mass index, red blood cell count, white blood cell count, total cholesterol, low-density lipoprotein cholesterol, and triglyceride and decreased high-density lipoprotein cholesterol were associated with impaired blood rheology measured by microchannel method in healthy subjects, suggesting that aging, obesity, erythrocytosis, leukocytosis, and dyslipidemia may be related to hemorheological disorders. This microchannel method may be useful to study blood rheology which may be associated with various risk factors of cardiovascular disorders.
Assuntos
Circulação Sanguínea/fisiologia , Adolescente , Adulto , Fatores Etários , Contagem de Células Sanguíneas , Velocidade do Fluxo Sanguíneo/fisiologia , Viscosidade Sanguínea/fisiologia , Índice de Massa Corporal , Feminino , Fibrinogênio/análise , Hemorreologia/instrumentação , Humanos , Lipídeos/sangue , Masculino , Pessoa de Meia-IdadeAssuntos
Tireotropina/sangue , Biomarcadores/sangue , Técnicas de Diagnóstico Endócrino , Retroalimentação Fisiológica , Humanos , Técnicas Imunoenzimáticas , Ensaio Imunorradiométrico , Medições Luminescentes , Hipófise/fisiopatologia , Valores de Referência , Manejo de Espécimes , Doenças da Glândula Tireoide/diagnósticoAssuntos
Autoanticorpos/sangue , Microssomos/imunologia , Autoanticorpos/imunologia , Biomarcadores/sangue , Doença de Graves/diagnóstico , Testes de Hemaglutinação/métodos , Humanos , Radioimunoensaio/métodos , Valores de Referência , Manejo de Espécimes , Testes de Função Tireóidea , Neoplasias da Glândula Tireoide/diagnóstico , Tireoidite Autoimune/diagnósticoRESUMO
Antipituitary antibody (APA) has been reported to be detected in patients with autoimmune thyroid disease. Type 2 iodothyronine deiodinase (D2) is expressed in both pituitary gland and thyroid gland. We studied the association of APA and D2 peptide antibody in patients with autoimmune thyroid disease. Rat pituitary gland homogenate and D2 peptide were used as antigens in the present study. APA and D2 peptide antibodies were measured by enzyme-linked immunosorbent assay (ELISA) in sera obtained from 42 patients with Hashimoto's disease, 26 patients with Graves' disease and 70 healthy control subjects. Moreover, D2 activity precipitation assay was performed in some patients with Hashimoto's disease. APA and D2 peptide antibody were elevated in patients with Hashimoto's disease and patients with Graves' disease, compared with control subjects. APA was positive in 32.4% (22/68), D2 peptide antibody was positive in 26.5% (18/68) of patients with autoimmune thyroid disease. APA was positive in 31.0% (13/42) of patients with Hashimoto's disease and 34.6% (9/26) of patients with Graves' disease. D2 peptide antibody was positive in 26.2% (11/42) of patients with Hashimoto's disease and 26.9% (7/26) of patients with Graves' disease. D2 peptide antibody was correlated with APA in patients with autoimmune thyroid disease. Moreover, precipitation of D2 activity was increased in some patients with Hashimoto's disease including a patient who also had idiopathic diabetes insipidus, and was correlated with D2 peptide antibody. These results suggest that D2 antibody may be associated with APA in patients with autoimmune thyroid disease.